John K. Lynch, Ph.D. has been appointed chief scientific officer at Cedarburg Hauser Pharmaceuticals. In his new role, Dr. Lynch will oversee all scientific operations including the process development, R&D and analytical groups.   Dr. Lynch has served as director of R&D for the last three years, where he oversaw development projects and led the scientific team. Prior to joining the company, Dr. Lynch spent 15 years at Abbott Laboratories, working on a variety of process development and ...